Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Hemorrhagic Events in Tumors and the Brain Linked to MAPK-Pathway Inhibitors: A Comprehensive Review and Mechanistic Analysis

  • By

  • Sudarshawn Damodharan

  • Alejandra Calderon

  • Mohamed S. Abdelbaki

  • July 15, 2026

Share

Original Source(s)

Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis

  • by Sudarshawn Damodharan, Alejandra Calderon, Mohamed S. Abdelbaki

  • July 15, 2026

Related Content

Fellowship-Trained Neuro-Oncologist Nishika Karbhari, M.D., Joins Baptist Health Herbert Wertheim Cancer Institute

Fellowship-trained neuro-oncologist Nishika Karbhari, M.D., has joined Baptist Health Herbert Wertheim Cancer Institute.

  • by

  • September 3, 2026

  • 2 min
Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis